| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02205333 Details | 2017-06-28 Interventional | 1/2 | 48 | Durvalumab Rituximab Tremelimumab Aggression Lymphoma Lymphoma, B-Cel… Advanced Solid … Aggressive B-ce… | The study was terminated early at the sponsor's discretion. The study was terminated early at the Sponsor's discretion. | |||
| NCT00331058 Details | 2017-06-28 Interventional | 1 | 58 | Prednisolone Asthma | The study was truncated due to the long period of enrollment and the collection of a sufficient
amount of data that allowed the scientific objectives to be met - | |||
| NCT02925533 Details | 2017-06-27 Interventional | 1 | 1 | Pembrolizumab Carcinoma, Tran… Urinary Bladder… Bladder Cancer | Terminated due to safety concerns. - | |||
| NCT02521077 Details | 2017-06-27 Interventional | 2 | 0 | Ascorbic Acid Fatigue | Manufacturer unwilling to provide information needed for IND application. - | |||
| NCT01756586 Details | 2017-06-27 Interventional | 4 | 4 | Bupivacaine Dexamethasone Analgesia Durat… | no logistical support to carry out the study fairly - | |||
| NCT01257802 Details | 2017-06-27 Interventional | 3 | 14 | Leuprolide Collagen Diseas… Lung Diseases Lung Diseases, … Lupus Erythemat… Rheumatic Disea… Scleroderma, Sy… Systemic Vascul… Vasculitis Isolated Angiit… Lung Disease In… Lung Disease Wi… | - - | |||
| NCT00636935 Details | 2017-06-27 Interventional | 4 | 0 | Anti-Bacterial … Antibiotics, An… Atovaquone Clindamycin Clindamycin pal… Clindamycin pho… Dapsone Pentamidine Prednisone Primaquine Trimethoprim Trimethoprim, S… Pneumonia Pneumonia, Pneu… Pneumocystis Ca… | No patient completed protocol - | |||
| NCT01868503 Details | 2017-06-26 Interventional | 2 | 7 | Lapatinib Breast Neoplasm… Breast Neoplasm… Recurrence Male Breast Can… Recurrent Breas… Stage IIIA Brea… Stage IIIB Brea… Stage IIIC Brea… | Protocol modification - | |||
| NCT01163253 2010-020002-15 Details | 2017-06-26 Interventional | 3 | 2867 | Tofacitinib Psoriasis | - - | |||
| NCT00375752 2004-004007-37 Details | 2017-06-26 Interventional | 4 | 168 | Letrozole Breast Neoplasm… | - Study terminated after 178 patients screened and 168 randomized, due to insufficient recruitment rate (no safety issues decided the reason to terminate study). LPLV for study was on 13-DEC-2010. LPLV of the 5-year follow-up period was on 03-FEB-2016. | |||
| NCT02161354 Details | 2017-06-23 Interventional | 2 | 52 | Buprenorphine Naloxone Toothache Dental Pain | safety and efficacy after cohort 5 did not warrant further dose escalation - | |||
| NCT01851720 Details | 2017-06-22 Interventional | 2/3 | 1 | Fentanyl Headache Hemorrhage Subarachnoid He… Headaches Assoc… | Inclusion criteria were too strict and therefore we were not able to recruit more patients. - | |||
| NCT01263574 Details | 2017-06-22 Interventional | 2 | 0 | Ethanol Catheter-Relate… Communicable Di… Infections Short Bowel Syn… Syndrome Catheter Relate… | No participants. IND denied by FDA. - | |||
| NCT00958022 Details | 2017-06-22 Interventional | 1 | 7 | Carboplatin Etoposide Etoposide phosp… Panobinostat Podophyllotoxin Lung Neoplasms Small Cell Lung… Small Cell Lung… | Based on the tolerabilty challenges of the combination - | |||
| NCT01943565 Details | 2017-06-19 Interventional | 4 | 29 | Hydromorphone Healthy Pain Pregnancy | Research question answered by another group of researchers (Sviggum et al) - | |||
| NCT00836875 2008-005275-10 Details | 2017-06-16 Interventional | 3 | 31 | Voriconazole Aspergillosis Invasive Asperg… | This protocol terminated prematurely on July 8, 2013 due to slow enrollment, not because of any
safety issues or concerns. The study was prematurely terminated due to slow enrollment. The study was not terminated due to any safety issues or concerns. Interpretation of the data are limited due to the small sample size and descriptive design. | |||
| NCT02410005 Details | 2017-06-15 Interventional | 2/3 | 56 | Calcitriol Dihydroxycholec… Losartan Diabetic Nephro… | Logistic challenges - | |||
| NCT02030314 Details | 2017-06-15 Interventional | 4 | 0 | Chlorthalidone Hypertension Resistant Hyper… | The patient population changed. Unable to find patients that meet study criteria - | |||
| NCT02698228 Details | 2017-06-14 Interventional | 4 | 0 | Bupivacaine Morphine Leg Injuries Wounds and Inju… Fracture Lower Limb Inju… | Study did not occur - | |||
| NCT02619812 Details | 2017-06-14 Interventional | 2 | 4 | Antibodies Colesevelam Hyd… Immunoglobulins Immunoglobulins… Diarrhea Multiple Myelom… Neoplasms, Plas… | Difficulty recruiting; pill burden and nausea were barriers This study was terminated early due to difficulty recruiting subjects; pill burden and nausea were barriers to study continuation for subjects accrued. Data were not collected. |